Skip to main content
Top
Published in: Pediatric Radiology 1/2009

01-01-2009 | Clinical Review

The spleen in the sickling disorders: an update

Authors: Rana Khatib, Raja Rabah, Sharada A. Sarnaik

Published in: Pediatric Radiology | Issue 1/2009

Login to get access

Abstract

In early life, patients with sickle cell disease (SCD) can have acute, life-threatening emergencies related to splenic hypofunction (overwhelming bacterial sepsis), as well as anemic crises from acute splenic sequestration because of sudden pooling of blood in the spleen. The landmark penicillin prophylaxis study in 1985 showed a remarkable decrease in mortality from sepsis in young children with SCD who were treated with oral penicillin prophylaxis compared to placebo. Since that study, newborns are screened for SCD and placed on oral penicillin prophylaxis in nearly all of the United States, as well as in other countries where the disease is highly prevalent. The previously described permanent, complete and nearly universal “autosplenectomy” emerging by late childhood or early adulthood is now challenged by recent findings of reversibility of splenic dysfunction by the antisickling drug hydroxyurea or by successful allogeneic stem cell transplantation, even in older patients. Imaging techniques for hypofunction of the spleen are the most commonly used modalities to guide the clinician in decisions regarding medical or surgical management.
Literature
1.
go back to reference Herrick JB (2001) Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. Yale J Biol Med 74:179–184PubMed Herrick JB (2001) Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. Yale J Biol Med 74:179–184PubMed
2.
go back to reference Pauling L, Itano HA, Singer SJ et al (1949) Sickle cell anemia, a molecular disease. Science 110:543–548PubMedCrossRef Pauling L, Itano HA, Singer SJ et al (1949) Sickle cell anemia, a molecular disease. Science 110:543–548PubMedCrossRef
3.
go back to reference Ataga KI, Cappellini MD, Rachmilewitz EA (2007) Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol 139:3–13PubMedCrossRef Ataga KI, Cappellini MD, Rachmilewitz EA (2007) Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol 139:3–13PubMedCrossRef
4.
go back to reference Ataga KI, Key NS (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007:91–96PubMed Ataga KI, Key NS (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program 2007:91–96PubMed
5.
go back to reference Ataga KI, Orringer EP (2003) Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 115:721–728PubMedCrossRef Ataga KI, Orringer EP (2003) Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 115:721–728PubMedCrossRef
7.
go back to reference Overturf G, Powars D (1980) Infections in sickle cell anemia: pathogenesis and control. Tex Rep Biol Med 40:283–292PubMed Overturf G, Powars D (1980) Infections in sickle cell anemia: pathogenesis and control. Tex Rep Biol Med 40:283–292PubMed
8.
go back to reference William BM, Corazza GR (2007) Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematology 12:1–13PubMedCrossRef William BM, Corazza GR (2007) Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematology 12:1–13PubMedCrossRef
9.
go back to reference Pearson HA, Spencer RP, Cornelius EA (1969) Functional asplenia in sickle-cell anemia. N Engl J Med 281:923–926PubMed Pearson HA, Spencer RP, Cornelius EA (1969) Functional asplenia in sickle-cell anemia. N Engl J Med 281:923–926PubMed
10.
go back to reference Dickerhoff R (2002) Splenic sequestration in patients with sickle cell disease. Klin Padiatr 214:70–73PubMedCrossRef Dickerhoff R (2002) Splenic sequestration in patients with sickle cell disease. Klin Padiatr 214:70–73PubMedCrossRef
11.
go back to reference Benjamin JT, McMillan CW, Komp DM (1979) Fatal splenic sequestration crisis. Va Med 106:679–680PubMed Benjamin JT, McMillan CW, Komp DM (1979) Fatal splenic sequestration crisis. Va Med 106:679–680PubMed
12.
go back to reference Walterspiel JN, Rutledge JC, Bartlett BL (1984) Fatal acute splenic sequestration at 4 months of age. Pediatrics 73:507–508PubMed Walterspiel JN, Rutledge JC, Bartlett BL (1984) Fatal acute splenic sequestration at 4 months of age. Pediatrics 73:507–508PubMed
13.
go back to reference Emond AM, Collis R, Darvill D et al (1985) Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 107:201–206PubMedCrossRef Emond AM, Collis R, Darvill D et al (1985) Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 107:201–206PubMedCrossRef
14.
go back to reference Grover R, Wethers DL (1990) Management of acute splenic sequestration crisis in sickle cell disease. J Assoc Acad Minor Phys 1:67–70PubMed Grover R, Wethers DL (1990) Management of acute splenic sequestration crisis in sickle cell disease. J Assoc Acad Minor Phys 1:67–70PubMed
15.
go back to reference Al-Salem AH, Naserullah Z, Qaisaruddin S et al (1999) Splenic complications of the sickling syndromes and the role of splenectomy. J Pediatr Hematol Oncol 21:401–406PubMedCrossRef Al-Salem AH, Naserullah Z, Qaisaruddin S et al (1999) Splenic complications of the sickling syndromes and the role of splenectomy. J Pediatr Hematol Oncol 21:401–406PubMedCrossRef
16.
go back to reference Delatte SJ, Hebra A, Tagge EP et al (1999) Acute chest syndrome in the postoperative sickle cell patient. J Pediatr Surg 34:188–191; discussion 191–192PubMedCrossRef Delatte SJ, Hebra A, Tagge EP et al (1999) Acute chest syndrome in the postoperative sickle cell patient. J Pediatr Surg 34:188–191; discussion 191–192PubMedCrossRef
17.
go back to reference Giebink GS, Le CT, Schiffman G (1984) Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides. J Pediatr 105:576–582PubMedCrossRef Giebink GS, Le CT, Schiffman G (1984) Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides. J Pediatr 105:576–582PubMedCrossRef
18.
go back to reference Wethers DL, Grover R (1987) Reversibility of splenic function by transfusion in two young adults with sickle cell anemia. Am J Pediatr Hematol Oncol 9:209–211PubMed Wethers DL, Grover R (1987) Reversibility of splenic function by transfusion in two young adults with sickle cell anemia. Am J Pediatr Hematol Oncol 9:209–211PubMed
19.
go back to reference Pearson HA, Cornelius EA, Schwartz AD et al (1970) Transfusion-reversible functional asplenia in young children with sickle-cell anemia. N Engl J Med 283:334–337PubMed Pearson HA, Cornelius EA, Schwartz AD et al (1970) Transfusion-reversible functional asplenia in young children with sickle-cell anemia. N Engl J Med 283:334–337PubMed
20.
go back to reference Buchanan GR, McKie V, Jackson EA et al (1989) Splenic phagocytic function in children with sickle cell anemia receiving long-term hypertransfusion therapy. J Pediatr 115:568–572PubMedCrossRef Buchanan GR, McKie V, Jackson EA et al (1989) Splenic phagocytic function in children with sickle cell anemia receiving long-term hypertransfusion therapy. J Pediatr 115:568–572PubMedCrossRef
21.
go back to reference Koren A, Haasz R, Tiatler A et al (1984) Serum immunoglobulin levels in children after splenectomy. A prospective study. Am J Dis Child 138:53–55PubMed Koren A, Haasz R, Tiatler A et al (1984) Serum immunoglobulin levels in children after splenectomy. A prospective study. Am J Dis Child 138:53–55PubMed
22.
go back to reference Shatney CH (1987) Complications of splenectomy. Acta Anaesthesiol Belg 38:333–339PubMed Shatney CH (1987) Complications of splenectomy. Acta Anaesthesiol Belg 38:333–339PubMed
23.
go back to reference Barrett DJ, Ammann AJ (1981) Pneumococcal vaccine in sickle cell disease: IgG and IgM antibody response. Rev Infect Dis 3 [Suppl]:S179–S182PubMed Barrett DJ, Ammann AJ (1981) Pneumococcal vaccine in sickle cell disease: IgG and IgM antibody response. Rev Infect Dis 3 [Suppl]:S179–S182PubMed
24.
go back to reference Risdon RA, Barry M, Flynn DM (1975) Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol 116:83–95PubMedCrossRef Risdon RA, Barry M, Flynn DM (1975) Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia. J Pathol 116:83–95PubMedCrossRef
25.
go back to reference Campbell PJ, Olatunji PO, Ryan KE et al (1997) Splenic regrowth in sickle cell anaemia following hypertransfusion. Br J Haematol 96:77–79PubMedCrossRef Campbell PJ, Olatunji PO, Ryan KE et al (1997) Splenic regrowth in sickle cell anaemia following hypertransfusion. Br J Haematol 96:77–79PubMedCrossRef
26.
go back to reference Wright JG, Hambleton IR, Thomas PW et al (1999) Postsplenectomy course in homozygous sickle cell disease. J Pediatr 134:304–309PubMedCrossRef Wright JG, Hambleton IR, Thomas PW et al (1999) Postsplenectomy course in homozygous sickle cell disease. J Pediatr 134:304–309PubMedCrossRef
27.
go back to reference Vichinsky E, Pakbaz Z, Onyekwere O et al (2008) Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol 119:133–141PubMedCrossRef Vichinsky E, Pakbaz Z, Onyekwere O et al (2008) Patient-reported outcomes of deferasirox (Exjade, ICL670) versus deferoxamine in sickle cell disease patients with transfusional hemosiderosis. Substudy of a randomized open-label phase II trial. Acta Haematol 119:133–141PubMedCrossRef
28.
go back to reference Wood JC, Ghurge N (2008) Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin 32:85–96PubMedCrossRef Wood JC, Ghurge N (2008) Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin 32:85–96PubMedCrossRef
30.
go back to reference Walker TM, Serjeant GR (1993) Focal echogenic lesions in the spleen in sickle cell disease. Clin Radiol 47:114–116PubMedCrossRef Walker TM, Serjeant GR (1993) Focal echogenic lesions in the spleen in sickle cell disease. Clin Radiol 47:114–116PubMedCrossRef
31.
go back to reference Levin TL, Berdon WE, Haller JO et al (1996) Intrasplenic masses of “preserved” functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol 26:646–649PubMedCrossRef Levin TL, Berdon WE, Haller JO et al (1996) Intrasplenic masses of “preserved” functioning splenic tissue in sickle cell disease: correlation of imaging findings (CT, ultrasound, MRI, and nuclear scintigraphy). Pediatr Radiol 26:646–649PubMedCrossRef
32.
go back to reference Casper JT, Koethe S, Rodey GE et al (1976) A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood 47:183–188PubMed Casper JT, Koethe S, Rodey GE et al (1976) A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood 47:183–188PubMed
33.
go back to reference Santos A, Pinheiro V, Anjos C et al (2002) Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease. Eur J Nucl Med Mol Imaging 29:536–541PubMedCrossRef Santos A, Pinheiro V, Anjos C et al (2002) Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease. Eur J Nucl Med Mol Imaging 29:536–541PubMedCrossRef
34.
go back to reference Hankins JS, Helton KJ, McCarville MB et al (2008) Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Pediatr Blood Cancer 50:293–297PubMedCrossRef Hankins JS, Helton KJ, McCarville MB et al (2008) Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Pediatr Blood Cancer 50:293–297PubMedCrossRef
35.
go back to reference Wang WC, Wynn LW, Rogers ZR et al (2001) A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 139:790–796PubMedCrossRef Wang WC, Wynn LW, Rogers ZR et al (2001) A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 139:790–796PubMedCrossRef
36.
go back to reference Claster S, Vichinsky E (1996) First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regeneration. Blood 88:1951–1953PubMed Claster S, Vichinsky E (1996) First report of reversal of organ dysfunction in sickle cell anemia by the use of hydroxyurea: splenic regeneration. Blood 88:1951–1953PubMed
37.
go back to reference Olivieri NF, Vichinsky EP (1998) Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy. J Pediatr Hematol Oncol 20:26–31PubMedCrossRef Olivieri NF, Vichinsky EP (1998) Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy. J Pediatr Hematol Oncol 20:26–31PubMedCrossRef
38.
go back to reference Ferster A, Bujan W, Corazza F et al (1993) Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood 81:1102–1105PubMed Ferster A, Bujan W, Corazza F et al (1993) Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood 81:1102–1105PubMed
Metadata
Title
The spleen in the sickling disorders: an update
Authors
Rana Khatib
Raja Rabah
Sharada A. Sarnaik
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
Pediatric Radiology / Issue 1/2009
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-008-1049-9

Other articles of this Issue 1/2009

Pediatric Radiology 1/2009 Go to the issue

Hermes

Hermes